Ensuring global access and equity in CGTs is critical to realise the promise of life-changing therapies. Achieving this aim will be utterly dependent on the coordinated efforts across research, regulation, manufacturing, and health systems to ensure CGT therapies are both accessible and affordable around the world. In our Cell & Gene Therapy World Congress, international leaders in policy, healthcare, and biotechnology will discuss strategies to improve access and strengthen collaboration across borders. This discussion will involve deliberations related to technology transfer, workforce development, regulatory harmonisation, and creating sustainable funding mechanisms that ensure inclusive participation in CGT innovation.